Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2015 Aug 17;54(34):9958-62.
doi: 10.1002/anie.201503978. Epub 2015 Jul 15.

All-Carbon [3+3] Oxidative Annulations of 1,3-Enynes by Rhodium(III)-Catalyzed C-H Functionalization and 1,4-Migration

Affiliations

All-Carbon [3+3] Oxidative Annulations of 1,3-Enynes by Rhodium(III)-Catalyzed C-H Functionalization and 1,4-Migration

David J Burns et al. Angew Chem Int Ed Engl. .

Abstract

1,3-Enynes containing allylic hydrogens cis to the alkyne function as three-carbon components in rhodium(III)-catalyzed, all-carbon [3+3] oxidative annulations to produce spirodialins. The proposed mechanism of these reactions involves the alkenyl-to-allyl 1,4-rhodium(III) migration.

Keywords: CH activation; allylation; enynes; homogeneous catalysis; rhodium.

PubMed Disclaimer

Figures

Scheme 1
Scheme 1
Catalytic oxidative annulations of alkynes and 1,3-enynes.
Figure 1
Figure 1
Biologically active spirocyclic barbiturates.
Scheme 2
Scheme 2
[a] Conducted with 0.50 mmol of 1 a–1 j. [b] Yield of isolated products. [b] Conducted with 0.5 mol % of [{Cp*RhCl2}2]. [c] Conducted in undried DMF. Side products were also obtained; see Ref. [14]. [d] Conducted at 120 °C. [e] Conducted with 5 mol % of [{Cp*RhCl2}2].
Scheme 3
Scheme 3
Possible catalytic cycle.
Scheme 4
Scheme 4
Formation of spiroindene 4 c from 1,3-enyne 2 k.
Scheme 5
Scheme 5
Oxidative annulation with a hexadeuterated 1,3-enyne.

Similar articles

Cited by

References

    1. Satoh T, Miura M. Chem. Eur. J. 2010;16:11212–11222. - PubMed
    1. Ackermann L. Acc. Chem. Res. 2014;47:281–295. - PubMed
    1. Shi G, Zhang Y. Adv. Synth. Catal. 2014;356:1419–1442. For selected reviews, see. - PMC - PubMed
    1. Kuhl N, Schröder N, Glorius F. Adv. Synth. Catal. 2014;356:1443–1460.
    1. De Sarkar S, Liu W, Kozhushkov SI, Ackermann L. Adv. Synth. Catal. 2014;356:1461–1479.